Industry-Expert Theater

Oncotype DX®: Personalizing Approaches to Locoregional Recurrence in Invasive Breast Cancer and DCIS

Tuesday, September 17
12:00 PM - 1:00 PM
Location: Theater 1, Innovation Hub

Presenters:
• Lawrence J. Solin, MD, FACR, FASTRO, Professor Emeritus, Dept. of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania
• Wendy A. Woodward, MD, PhD, Professor, Dep. of Radiation Oncology, and Service Chief, Breast Cancer Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center


Please join us for a discussion surrounding the use of the Oncotype DX Breast Recurrence Score® test to predict the risk of locoregional recurrence in ER-positive, node-positive patients and identify those with low risk Recurrence Scores that may avoid post-mastectomy radiation or regional nodal radiation following lumpectomy/whole breast radiation. Prospective validation studies will also be presented to support the use of the Oncotype DX Breast DCIS Score® test as a prognostic tool that provides an individual’s 10-year risk of any local recurrence and invasive local recurrence after breast conserving surgery to assist in radiation treatment decisions.


Company: Genomic Health
Contact: Ann Kopischke
Phone:206-779-9089
Email: akopischke@genomichealth.com


Assets

Oncotype DX®: Personalizing Approaches to Locoregional Recurrence in Invasive Breast Cancer and DCIS



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Oncotype DX®: Personalizing Approaches to Locoregional Recurrence in Invasive Breast Cancer and DCIS